Logo image of AKZA.AS

AKZO NOBEL N.V. (AKZA.AS) Stock Fundamental Analysis

AMS:AKZA - Euronext Amsterdam - NL0013267909 - Common Stock - Currency: EUR

60.42  -1 (-1.63%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to AKZA. AKZA was compared to 68 industry peers in the Chemicals industry. While AKZA belongs to the best of the industry regarding profitability, there are concerns on its financial health. AKZA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

AKZA had positive earnings in the past year.
AKZA had a positive operating cash flow in the past year.
In the past 5 years AKZA has always been profitable.
Each year in the past 5 years AKZA had a positive operating cash flow.
AKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFAKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

AKZA has a Return On Assets of 3.15%. This is in the better half of the industry: AKZA outperforms 63.24% of its industry peers.
AKZA has a Return On Equity of 10.12%. This is in the better half of the industry: AKZA outperforms 69.12% of its industry peers.
AKZA has a better Return On Invested Capital (5.60%) than 67.65% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AKZA is in line with the industry average of 6.10%.
The 3 year average ROIC (5.38%) for AKZA is below the current ROIC(5.60%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.15%
ROE 10.12%
ROIC 5.6%
ROA(3y)3.08%
ROA(5y)4%
ROE(3y)10.07%
ROE(5y)11.29%
ROIC(3y)5.38%
ROIC(5y)6.02%
AKZA.AS Yearly ROA, ROE, ROICAKZA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

Looking at the Profit Margin, with a value of 4.38%, AKZA is in the better half of the industry, outperforming 64.71% of the companies in the same industry.
AKZA's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 7.94%, AKZA is in the better half of the industry, outperforming 67.65% of the companies in the same industry.
In the last couple of years the Operating Margin of AKZA has remained more or less at the same level.
AKZA's Gross Margin of 40.23% is fine compared to the rest of the industry. AKZA outperforms 60.29% of its industry peers.
AKZA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.94%
PM (TTM) 4.38%
GM 40.23%
OM growth 3Y-9.79%
OM growth 5Y-1.14%
PM growth 3Y-16.36%
PM growth 5Y-2.73%
GM growth 3Y-0.19%
GM growth 5Y-1.09%
AKZA.AS Yearly Profit, Operating, Gross MarginsAKZA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

AKZA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AKZA has about the same amount of shares outstanding.
The number of shares outstanding for AKZA has been reduced compared to 5 years ago.
Compared to 1 year ago, AKZA has an improved debt to assets ratio.
AKZA.AS Yearly Shares OutstandingAKZA.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AKZA.AS Yearly Total Debt VS Total AssetsAKZA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

AKZA has an Altman-Z score of 2.15. This is not the best score and indicates that AKZA is in the grey zone with still only limited risk for bankruptcy at the moment.
AKZA has a Altman-Z score (2.15) which is in line with its industry peers.
The Debt to FCF ratio of AKZA is 15.02, which is on the high side as it means it would take AKZA, 15.02 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AKZA (15.02) is comparable to the rest of the industry.
AKZA has a Debt/Equity ratio of 0.90. This is a neutral value indicating AKZA is somewhat dependend on debt financing.
The Debt to Equity ratio of AKZA (0.90) is worse than 73.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 15.02
Altman-Z 2.15
ROIC/WACC0.97
WACC5.76%
AKZA.AS Yearly LT Debt VS Equity VS FCFAKZA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

AKZA has a Current Ratio of 1.36. This is a normal value and indicates that AKZA is financially healthy and should not expect problems in meeting its short term obligations.
AKZA has a worse Current ratio (1.36) than 69.12% of its industry peers.
A Quick Ratio of 0.99 indicates that AKZA may have some problems paying its short term obligations.
AKZA has a Quick ratio (0.99) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 0.99
AKZA.AS Yearly Current Assets VS Current LiabilitesAKZA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.23% over the past year.
The Earnings Per Share has been growing slightly by 4.44% on average over the past years.
Looking at the last year, AKZA shows a small growth in Revenue. The Revenue has grown by 0.31% in the last year.
The Revenue has been growing slightly by 2.92% on average over the past years.
EPS 1Y (TTM)7.23%
EPS 3Y-1.33%
EPS 5Y4.44%
EPS Q2Q%-16.07%
Revenue 1Y (TTM)0.31%
Revenue growth 3Y3.76%
Revenue growth 5Y2.92%
Sales Q2Q%-1.02%

3.2 Future

Based on estimates for the next years, AKZA will show a small growth in Earnings Per Share. The EPS will grow by 7.13% on average per year.
AKZA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.86% yearly.
EPS Next Y15.13%
EPS Next 2Y13.67%
EPS Next 3Y11.33%
EPS Next 5Y7.13%
Revenue Next Year0.88%
Revenue Next 2Y1.63%
Revenue Next 3Y1.99%
Revenue Next 5Y1.86%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AKZA.AS Yearly Revenue VS EstimatesAKZA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
AKZA.AS Yearly EPS VS EstimatesAKZA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.29, which indicates a correct valuation of AKZA.
Compared to the rest of the industry, the Price/Earnings ratio of AKZA indicates a somewhat cheap valuation: AKZA is cheaper than 76.47% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. AKZA is valued slightly cheaper when compared to this.
AKZA is valuated correctly with a Price/Forward Earnings ratio of 12.02.
73.53% of the companies in the same industry are more expensive than AKZA, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of AKZA to the average of the S&P500 Index (21.76), we can say AKZA is valued slightly cheaper.
Industry RankSector Rank
PE 16.29
Fwd PE 12.02
AKZA.AS Price Earnings VS Forward Price EarningsAKZA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as AKZA.
61.76% of the companies in the same industry are more expensive than AKZA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 26.32
EV/EBITDA 11.79
AKZA.AS Per share dataAKZA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of AKZA may justify a higher PE ratio.
PEG (NY)1.08
PEG (5Y)3.67
EPS Next 2Y13.67%
EPS Next 3Y11.33%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.27%, AKZA has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.08, AKZA pays a bit more dividend than its industry peers.
AKZA's Dividend Yield is a higher than the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 3.27%

5.2 History

The dividend of AKZA decreases each year by -21.52%.
Dividend Growth(5Y)-21.52%
Div Incr Years0
Div Non Decr Years4
AKZA.AS Yearly Dividends per shareAKZA.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

81.84% of the earnings are spent on dividend by AKZA. This is not a sustainable payout ratio.
DP81.84%
EPS Next 2Y13.67%
EPS Next 3Y11.33%
AKZA.AS Yearly Income VS Free CF VS DividendAKZA.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
AKZA.AS Dividend Payout.AKZA.AS Dividend Payout, showing the Payout Ratio.AKZA.AS Dividend Payout.PayoutRetained Earnings

AKZO NOBEL N.V.

AMS:AKZA (7/11/2025, 7:00:00 PM)

60.42

-1 (-1.63%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-23 2025-04-23/bmo
Earnings (Next)07-23 2025-07-23
Inst Owners63.22%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap10.32B
Analysts76.8
Price Target71.64 (18.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.27%
Yearly Dividend1.98
Dividend Growth(5Y)-21.52%
DP81.84%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.89%
Min EPS beat(2)-27.6%
Max EPS beat(2)-4.18%
EPS beat(4)0
Avg EPS beat(4)-10.18%
Min EPS beat(4)-27.6%
Max EPS beat(4)-2.11%
EPS beat(8)1
Avg EPS beat(8)-11.08%
EPS beat(12)2
Avg EPS beat(12)-14.56%
EPS beat(16)4
Avg EPS beat(16)-11.07%
Revenue beat(2)1
Avg Revenue beat(2)-0.21%
Min Revenue beat(2)-2.21%
Max Revenue beat(2)1.79%
Revenue beat(4)1
Avg Revenue beat(4)-1.37%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.16%
Revenue beat(12)3
Avg Revenue beat(12)-1.21%
Revenue beat(16)3
Avg Revenue beat(16)-1.49%
PT rev (1m)0.74%
PT rev (3m)-2.83%
EPS NQ rev (1m)-0.81%
EPS NQ rev (3m)-7.79%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.75%
Revenue NQ rev (1m)0.36%
Revenue NQ rev (3m)-3.96%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2%
Valuation
Industry RankSector Rank
PE 16.29
Fwd PE 12.02
P/S 0.97
P/FCF 26.32
P/OCF 14.17
P/B 2.23
P/tB 16.3
EV/EBITDA 11.79
EPS(TTM)3.71
EY6.14%
EPS(NY)5.03
Fwd EY8.32%
FCF(TTM)2.3
FCFY3.8%
OCF(TTM)4.26
OCFY7.06%
SpS62.56
BVpS27.08
TBVpS3.71
PEG (NY)1.08
PEG (5Y)3.67
Profitability
Industry RankSector Rank
ROA 3.15%
ROE 10.12%
ROCE 8.43%
ROIC 5.6%
ROICexc 6.8%
ROICexgc 13.12%
OM 7.94%
PM (TTM) 4.38%
GM 40.23%
FCFM 3.67%
ROA(3y)3.08%
ROA(5y)4%
ROE(3y)10.07%
ROE(5y)11.29%
ROIC(3y)5.38%
ROIC(5y)6.02%
ROICexc(3y)6.53%
ROICexc(5y)7.21%
ROICexgc(3y)12.06%
ROICexgc(5y)13.03%
ROCE(3y)9.71%
ROCE(5y)10.22%
ROICexcg growth 3Y-10.53%
ROICexcg growth 5Y-0.19%
ROICexc growth 3Y-9.99%
ROICexc growth 5Y-0.31%
OM growth 3Y-9.79%
OM growth 5Y-1.14%
PM growth 3Y-16.36%
PM growth 5Y-2.73%
GM growth 3Y-0.19%
GM growth 5Y-1.09%
F-Score4
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 15.02
Debt/EBITDA 3.41
Cap/Depr 89.36%
Cap/Sales 3.14%
Interest Coverage 5.08
Cash Conversion 59.48%
Profit Quality 83.76%
Current Ratio 1.36
Quick Ratio 0.99
Altman-Z 2.15
F-Score4
WACC5.76%
ROIC/WACC0.97
Cap/Depr(3y)80.65%
Cap/Depr(5y)79.09%
Cap/Sales(3y)2.74%
Cap/Sales(5y)2.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.23%
EPS 3Y-1.33%
EPS 5Y4.44%
EPS Q2Q%-16.07%
EPS Next Y15.13%
EPS Next 2Y13.67%
EPS Next 3Y11.33%
EPS Next 5Y7.13%
Revenue 1Y (TTM)0.31%
Revenue growth 3Y3.76%
Revenue growth 5Y2.92%
Sales Q2Q%-1.02%
Revenue Next Year0.88%
Revenue Next 2Y1.63%
Revenue Next 3Y1.99%
Revenue Next 5Y1.86%
EBIT growth 1Y-23.47%
EBIT growth 3Y-6.39%
EBIT growth 5Y1.75%
EBIT Next Year40.9%
EBIT Next 3Y17.11%
EBIT Next 5Y10.36%
FCF growth 1Y4800%
FCF growth 3Y4.63%
FCF growth 5YN/A
OCF growth 1Y138.69%
OCF growth 3Y3.41%
OCF growth 5Y96.16%